Catalyst Wire Dossier Catalyst Wire Dossier

BLB-201 RSV Vaccine

BLB-201 RSV vaccine · Blue Lake Biotechnology Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BLB-201 RSV Vaccine, covering 2025-12-15 to 2025-12-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of BLB-201 RSV Vaccine in Infants and Children [Phase 1, Phase 2]

See pricing